510(k) Report

510(k) · Cleared

Cleared

Elecsys Rubella Igg Immunoassay

K072617510(k) TraditionalCleared Dec 5, 2008445-day reviewClass II21 CFR 866.3510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · LFX Enzyme Linked Immunoabsorbent Assay, Rubella

Cleared on Dec 5, 2008 as substantially equivalent to K983805 (Zeus Scientific, Inc., 1999) and 1 other predicate after a 445-day review. Its family tree reaches back 1 generation to 1999. 2 later devices descend from it.

Decided
Dec 5, 2008
Review
445 days
Class
Class II
Product code
LFX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K983805 (1999). 2 ancestors in all. 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1999: 1 other ancestor2014: 1 descendant cleared2022: 1 descendant clearedK983805 · The Aptus (Automated) Application of the Rubella Igg Elisa Test System. an Enzyme Linked Immunosorbent Assay (Elisa) FO · Zeus Scientific, Inc. · 19991995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 1 descendant K983805 · The Aptus (Automated) Application of the Rubella Igg Elisa Test System. an Enzyme Linked Immunosorbent Assay (Elisa) FO · Zeus Scientific, Inc. · 19990
  1. Root · 1 generation backK983805 The Aptus (Automated) Application of the Rubella Igg Elisa Test…Zeus Scientific, Inc. · 1999
  2. This deviceK072617 Elecsys Rubella Igg ImmunoassayRoche Diagnostics Corp. · 2008
  3. Descendant · cites it directly · 1 of its ownK131605 Elecsys Precicontrol CMV Igg, Elecsys CMV Igg ImmunoassayRoche Diagnostics · 2014
  4. Descendant · 2 generations on · 0 of its ownK220911 Elecsys CMV IgGRoche Diagnostics · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K131605Elecsys Precicontrol CMV Igg, Elecsys CMV Igg ImmunoassayRoche Diagnostics · 2014 · cites it directly1descendant
  • K220911Elecsys CMV IgGRoche Diagnostics · 2022 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K983805The Aptus (Automated) Application of the Rubella Igg Elisa Test System. an…Zeus Scientific, Inc.1999—
0 (this device)K072617Elecsys Rubella Igg ImmunoassayRoche Diagnostics Corp.2008—
+1K131605Elecsys Precicontrol CMV Igg, Elecsys CMV Igg ImmunoassayRoche Diagnostics2014—
+2K220911Elecsys CMV IgGRoche Diagnostics2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
202210
FIG. 1 — Lineage of K072617, 1999–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LFX device

  1. #1 K250588 Access Rubella IgGscore 10.4 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K983805The Aptus (Automated) Application of the Rubella Igg Elisa Test System. an Enzyme Linked…
Summary page 2
…ted States. equivalence Elecsys Rubella IgG Immunoassay is equivalent to the Zeus Scientific Rubella IgG ELISA Test System cleared in K983805 510(k) Summary, Continued Substantial equivalence - similarities (1) Rubella IgG Im…
Zeus Scientific, Inc.1999—
*K984180The Aptus (Automated) Application of the Rubella Igm Elisa Test System
Summary page 3
…ce: Zeus Scientific Immunoassay Rubella IgG ELISA Test System (K984180) Intended Use The Elecsys Rubella IgG The Zeus Scientific, Inc. Laboratories immunoass…
Zeus Scientific, Inc.19991

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131605Elecsys Precicontrol CMV Igg, Elecsys CMV Igg ImmunoassayRoche Diagnostics20141

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K131605 (Roche Diagnostics, 2014) has gone furthest, with 1 descendant of its own.

How does its category compare?

All LFX devices

LFX Enzyme Linked Immunoabsorbent Assay, Rubella: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · LFX

2in 2025

2007: 12008: 32010: 22011: 12012: 12025: 2
2007high 3 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFX

354in 2008

2008: 354 days median
2007high 354 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LFX

1in 2021

2007: 22008: 22009: 32010: 22011: 12016: 22021: 1
2007high 3 (2009) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFX

12in 2025

2007: 52008: 3672009: 192010: 182011: 892012: 372013: 152014: 132015: 152016: 472017: 102018: 242019: 162020: 212021: 132022: 132023: 72024: 132025: 12
2007high 367 (2008) · low 5 (2007)2025

MAUDE reports naming product code LFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—25
200833542367
20090—319
20102—218
20111—189
20121—037
20130—015
20140—013
20150—015
20160—247
20170—010
20180—024
20190—016
20200—021
20210—113
20220—013
20230—07
20240—013
20252—012
20260—0—

What is it indicated for?

The Elecsys Rubella IgG immunoassay is for the in vitro quantitative determination of IgG antibodies to rubella virus in human serum and Li-heparin, K3-EDTA and sodium citrate plasma.

This assay may be used as an aid in the assessment of immune status to rubella in individuals including women of childbearing age.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on Elecsys and cobas e immunoassay analyzers.

Elecsys PreciControl Rubella IgG is used for quality control of the Elecsys Rubella IgG immunoassay on the Elecsys and cobas e immunoassay analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072617: Elecsys Rubella Igg Immunoassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072617

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026